| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $1.2M | +51.5% | +68.2% |
| SG&A Expense | $1.3M | -25.2% | +47.0% |
| Operating Income | -$2.5M | +1.0% | -56.5% |
| Pre-tax Income | -$2.3M | +3.1% | -38.1% |
| Income Tax | $2K | — | — |
| Net Income | -$2.3M | +3.1% | -38.1% |
| EPS (Basic) | -$0.27 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.1M | -27.0% | +2079.5% |
| Current Assets | $5.6M | -25.6% | +294.1% |
| Total Assets | $7.7M | -20.2% | +116.8% |
| Current Liabilities | $1.2M | +1.8% | -78.7% |
| Total Liabilities | $2.3M | -4.0% | -67.3% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.5M | — | — |
| Capital Expenditures | $95K | — | — |
| Investing Cash Flow | -$75K | — | — |
| Financing Cash Flow | -$17K | — | — |
| Free Cash Flow | -$4.6M | — | — |
| +0.0% |
| EPS (Diluted) | -$0.27 | +3.6% | +0.0% |
| $5.4M |
| -25.7% |
| +249.2% |